Institute for Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland
Cancer Genetics and Evolution Laboratory, Edinburgh Cancer Research Centre, Edinburgh, UK.
J Med Genet. 2021 Jan;58(1):20-24. doi: 10.1136/jmedgenet-2019-106734. Epub 2020 Mar 16.
Although considerable effort has been put into decoding of the osteosarcoma genome, very little is known about germline mutations that underlie this primary malignant tumour of bone.
We followed here a coincidental finding in a multiple endocrine neoplasia family in which a 32-year-old patient carrying a germline pathogenic mutation developed an osteosarcoma 2 years after the resection of a medullary thyroid carcinoma. Sequencing analysis of additional 336 patients with osteosarcoma led to the identification of germline activating mutations in the proto-oncogene in three cases and somatic amplifications of the gene locus in five matched tumours (4%, n=5/124 tumours). Functional analysis of the pathogenic variants together with an integrative analysis of osteosarcoma genomes confirmed that the mutant RET proteins couple functional kinase activity to dysfunctional ligand binding. mutations further co-operated with alterations in and , suggesting that osteosarcoma pathogenesis bears reminiscence to the stepwise model of medullary thyroid carcinoma.
After Li-Fraumeni-predisposing mutations in , becomes the second most mutated cancer-predisposing gene in the germline of patients with osteosarcoma. Hence, early identification of mutation carriers can help to identify at-risk family members and carry out preventive measures.
尽管在解码骨肉瘤基因组方面已经付出了相当大的努力,但对于构成这种原发性骨恶性肿瘤的种系突变却知之甚少。
在这里,我们遵循一个偶然的发现,即一个多发性内分泌肿瘤家族中的一名 32 岁患者携带种系致病性突变,在切除髓样甲状腺癌 2 年后发展为骨肉瘤。对另外 336 名骨肉瘤患者进行测序分析,在 3 例中发现原癌基因中的种系激活突变,在 5 例匹配的肿瘤中发现基因位点的体细胞扩增(4%,n=5/124 肿瘤)。对致病性变异的功能分析以及骨肉瘤基因组的综合分析证实,突变的 RET 蛋白将功能性激酶活性与功能失调的配体结合耦合在一起。进一步的突变还与 和 的改变协同作用,表明骨肉瘤的发病机制与髓样甲状腺癌的逐步模型有相似之处。
在 种 Li-Fraumeni 易感性突变之后, 成为骨肉瘤患者种系中第二个突变频率最高的癌症易感性基因。因此,早期识别 突变携带者有助于识别高危家庭成员并采取预防措施。